Steven J. Drews

8.6k total citations · 1 hit paper
186 papers, 3.9k citations indexed

About

Steven J. Drews is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, Steven J. Drews has authored 186 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Epidemiology, 98 papers in Infectious Diseases and 30 papers in Microbiology. Recurrent topics in Steven J. Drews's work include Respiratory viral infections research (58 papers), Influenza Virus Research Studies (56 papers) and SARS-CoV-2 and COVID-19 Research (34 papers). Steven J. Drews is often cited by papers focused on Respiratory viral infections research (58 papers), Influenza Virus Research Studies (56 papers) and SARS-CoV-2 and COVID-19 Research (34 papers). Steven J. Drews collaborates with scholars based in Canada, United States and United Kingdom. Steven J. Drews's co-authors include Cameron Griffiths, David Marchant, Nathalie Bastien, Danuta M. Skowronski, Gaston De Serres, Jonathan B. Gubbay, James A. Dickinson, Mel Krajden, Catharine Chambers and David N. Fisman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Steven J. Drews

176 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment

2016 420 citations Cameron Griffiths, Steven J. Drews et al. profile →

Peers

Steven J. Drews

EPIDE

MICRO

PRM

Ángela Domı́nguez Spain

Tomàs Pumarola Spain

Woo Joo Kim South Korea

Tawee Chotpitayasunondh Thailand

Thedi Ziegler Finland

Paul Van Caeseele Canada

Kathleen Harriman United States

Kathrin Mühlemann Switzerland

James Watt United States

Kulkanya Chokephaibulkit Thailand

Ángela Domı́nguez Spain

Steven J. Drews

2.6k ×1.0

EPIDE

1.4k ×0.8

507 ×0.8

MICRO

310 ×0.7

239 ×0.9

PRM

Citations per year, relative to Steven J. Drews Steven J. Drews (= 1×) peers Ángela Domı́nguez

Countries citing papers authored by Steven J. Drews

Since Specialization

Citations

This map shows the geographic impact of Steven J. Drews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven J. Drews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven J. Drews more than expected).

Fields of papers citing papers by Steven J. Drews

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven J. Drews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven J. Drews. The network helps show where Steven J. Drews may publish in the future.

Co-authorship network of co-authors of Steven J. Drews

This figure shows the co-authorship network connecting the top 25 collaborators of Steven J. Drews. A scholar is included among the top collaborators of Steven J. Drews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven J. Drews. Steven J. Drews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goldman, Mindy, Steven J. Drews, Chanson J. Brumme, et al.. (2025). Nondisclosure of use of antiretroviral medications in Canadian blood donors. Transfusion. 65(10). 1869–1875.

O’Brien, Sheila F., et al.. (2025). Influenza and COVID‐19 vaccination in Canadian blood donors: A comparison across pre‐ and post‐pandemic periods. Vox Sanguinis. 120(5). 464–472.

O’Brien, Sheila F., et al.. (2024). Epidemiology of Hepatitis C over 28 years of monitoring Canadian blood donors: Insight into a low-risk undiagnosed population. BMC Public Health. 24(1). 2319–2319. 2 indexed citations

Lewin, Antoine, Mindy Goldman, Michael P. Busch, et al.. (2024). End of selection criteria based on sexual orientation: An international symposium on alternatives to donation deferral. Vox Sanguinis. 119(4). 388–401. 7 indexed citations

Renaud, Christian, Antoine Lewin, Yves Grégoire, et al.. (2024). SARS‐CoV‐2 immunoassays in a predominantly vaccinated population: Performances and qualitative agreements obtained with two analytical approaches and four immunoassays. Vox Sanguinis. 119(6). 533–540. 2 indexed citations

Lin, Yi-Chan, David H. Evans, Kento T. Abe, et al.. (2023). Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021. Microbiology Spectrum. 11(4). e0525622–e0525622.

Asamoah-Boaheng, Michael, Brian Grunau, Mohammad Ehsanul Karim, et al.. (2023). Eleven-month SARS-CoV-2 binding antibody decay, and associated factors, among mRNA vaccinees: implications for booster vaccination. Access Microbiology. 5(11). 2 indexed citations

Bhullar, Khushwant S., Manal A. Nael, Khaled M. Elokely, Steven J. Drews, & Jianping Wu. (2022). Structurally Modified Bioactive Peptide Inhibits SARS-CoV-2 Lentiviral Particles Expression. Pharmaceutics. 14(10). 2045–2045. 1 indexed citations

Lin, Yi-Chan, David H. Evans, Queenie Hu, et al.. (2022). Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses. Microbiology Spectrum. 10(5). e0281122–e0281122. 7 indexed citations

10.

Saeed, Sahar, Sheila F. O’Brien, Kento T. Abe, et al.. (2021). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard. PLoS ONE. 16(9). e0257743–e0257743. 12 indexed citations

11.

Savage, Rachel, Christopher Bell, Christiaan H. Righolt, et al.. (2021). A multisite study of pertussis vaccine effectiveness by time since last vaccine dose from three Canadian provinces: A Canadian Immunization Research Network study. Vaccine. 39(20). 2772–2779. 3 indexed citations

12.

Saeed, Sahar, et al.. (2021). SARS‐CoV‐2 seroprevalence among blood donors after the first COVID‐19 wave in Canada. Transfusion. 61(3). 862–872. 35 indexed citations

13.

Lewin, Antoine, Steven J. Drews, Christian Erikstrup, et al.. (2021). An international comparison of anti‐SARS‐COV‐2 assays used for seroprevalence surveys from blood component providers. Vox Sanguinis. 116(9). 946–954. 9 indexed citations

14.

LEBLANC, J, Marc Germain, Gilles Delage, et al.. (2020). Risk of transmission of severe acute respiratory syndrome coronavirus 2 by transfusion: A literature review. Transfusion. 60(12). 3046–3054. 30 indexed citations

15.

Scott, Allison N., Sarah A. Buchan, Jeffrey C. Kwong, et al.. (2019). Using population-wide administrative and laboratory data to estimate type- and subtype-specific influenza vaccine effectiveness: a surveillance protocol. BMJ Open. 9(9). e029708–e029708. 3 indexed citations

16.

Griffiths, Cameron, Leanne M. Bilawchuk, Julian W. Tang, et al.. (2017). A Virological and Phylogenetic Analysis of the Emergence of New Clades of Respiratory Syncytial Virus. Scientific Reports. 7(1). 12232–12232. 11 indexed citations

17.

Zhuo, Ran, Brendon Parsons, Bonita E. Lee, et al.. (2017). Identification of Enteric Viruses in Oral Swabs from Children with Acute Gastroenteritis. Journal of Molecular Diagnostics. 20(1). 56–62. 17 indexed citations

18.

Martín, Irene, Vanessa Allen, Brigitte Lefebvre, et al.. (2015). Decline in Decreased Cephalosporin Susceptibility and Increase in Azithromycin Resistance inNeisseria gonorrhoeae, Canada. Emerging infectious diseases. 22(1). 65–67. 33 indexed citations

19.

Janjua, Naveed Z., Danuta M. Skowronski, Gaston De Serres, et al.. (2012). Estimates of Influenza Vaccine Effectiveness for 2007–2008 From Canada's Sentinel Surveillance System: Cross-Protection Against Major and Minor Variants. The Journal of Infectious Diseases. 205(12). 1858–1868. 48 indexed citations

20.

Drews, Steven J., et al.. (2008). Use of the Seeplex RV Detection kit for surveillance of respiratory viral outbreaks in Toronto, Ontario, Canada.. PubMed. 38(4). 376–9. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact